The prevalence of antibody to hepatitis C virus (anti-HCV) was investigated in patients with hepatocellular carcinoma (HCC), and correlated with the clinical features. Anti-HCV was detected in 129 histology or aspiration cytology proven HCC patients and 54 healthy controls. Anti-HCV was examined by
Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
✍ Scribed by Dr. G. Sbolli; A. R. Zanetti; E. Tanzi; L. Cavanna; G. Civardi; F. Fornari; M. Di Stasi; L. Buscarini
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 270 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Antibodies against hepatitis C virus (anti‐HCV) were detected in 60.8% of 78 patients with hepatocellular carcinoma (HCC). Cirrhosis, present in most of the patients, as well as alcohol abuse, age, sex, and α‐fetoprotein were equally distributed in the anti‐HCV‐positive and ‐negative groups. HBsAg positivity was significatively higher in negative anti‐HCV group. By contrast, hepatitis B virus (HBV) antibodies were detected more frequently in positive anti‐HCV patients than in the negative anti‐HCV group. These data must be considered with caution becuase of the small number of HBsAg‐positive patients. It is concluded that the high prevalence of anti‐HCV in patients with HCC may suggest an etiological role of the hepatitis C virus, although in relationship to age, alcohol abuse and cirrhosis, the similarity in the two groups questions this hypothesis.
📜 SIMILAR VOLUMES
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for
The prevalence of antibodies to hepatitis C virus (HCVAb) was investigated in 52 unselected patients with mixed cryoglobulinemia and in 84 patients with other systemic immunologic diseases. HCVAb were detected by an enzyme-linked immunosorbent assay, and their specificity was evaluated by a recombin
We have cloned the whole structural region of the hepatitis C virus (HCV) genome and transiently expressed the nucleocapsid protein in animal cells. Since the nucleotide sequences of this region of the HCV genome has been shown to be highly conserved among different HCV isolates, the assay detecting